Enkrisi’s Client Login
EnkrisiGPT
PharmWrite is a digital solution that allows organizations and sponsor companies to manage their regulatory submission obligations in an automated, centralized way. The platform utilizes various technologies, including machine learning, natural language processing, advanced OCR, and analytics, to enable compliance with applicable laws and regulations. Data collected within the platform can be analyzed for insights that help the organization comply with changing legal requirements. Additionally, the platform can help an organization react quickly to regulations or market conditions changes, allowing them to remain competitive without sacrificing compliance or delay to approval.
PharmWrite offers automation, centralized management, insights, analytics, adaptability to regulatory changes, and specialization in FDA submissions and CMC aspects. Choosing PharmWrite can enhance an organization’s regulatory compliance, streamline processes, and facilitate successful approvals for regulated products.
For many biotechnology companies, maintaining a full complement of product development experts, from drug development technical experts to submission authors and regulatory professionals is impossible. However, lacking access to these experts hinders the progress of product development.
PharmWrite’s hybrid model consultancy distinguishes itself through the combination of automation and expertise, data-driven insights, agility in the regulatory landscape, and specialization in FDA submissions and CMC. By embracing this innovative approach, PharmWrite empowers organizations to achieve regulatory compliance efficiently, make informed decisions, adapt to changes seamlessly, and maximize their chances of successful approvals.
Augmented Intelligence is a form of A.I. that works in tandem with humans to make decisions rather than replace human Intelligence. It uses machine learning and deep learning algorithms to provide actionable data to help humans make informed decisions. Machine learning allows A.I. systems to learn and improve from experience. Natural language processing lets computers understand our spoken language, while deep learning helps them “think” like the human brain and find patterns in large data sets. Augmented Intelligence starkly contrasts traditional artificial Intelligence, which seeks to replace human labor and decision-making altogether.
PharmWrite’s hybrid model consultancy distinguishes itself through the combination of automation and expertise, data-driven insights, agility in the regulatory landscape, and specialization in FDA submissions and CMC. By embracing this innovative approach, PharmWrite empowers organizations to achieve regulatory compliance efficiently, make informed decisions, adapt to changes seamlessly, and maximize their chances of successful approvals.
PharmWrite works by leveraging automation and centralization to streamline regulatory compliance processes. Organizations can upload their regulatory submission materials to the platform, which utilizes advanced technologies like machine learning, natural language processing, advanced OCR, and analytics. These technologies automate manual tasks, extract relevant information from documents, and streamline data entry, reducing the risk of errors and saving time. The centralization aspect allows all stakeholders involved in the compliance process to access and collaborate on the platform, ensuring transparency, efficiency, and consistency in managing regulatory obligations.
A key aspect of PharmWrite is its ability to collect and analyze data, providing valuable insights for regulatory compliance. The platform's analytics capabilities enable organizations to gain a deeper understanding of their regulatory landscape. By analyzing trends, patterns, and historical data, organizations can proactively identify potential compliance risks, make data-driven decisions, and optimize their compliance strategies. PharmWrite empowers organizations to extract actionable insights from vast amounts of regulatory data, facilitating more effective compliance management and reducing the chances of non-compliance.
PharmWrite offers expert guidance and collaboration throughout the regulatory compliance process. Organizations can access a team of regulatory professionals who specialize in FDA submissions and CMC aspects. These experts provide personalized guidance, ensuring that organizations understand and meet the regulatory requirements for their specific products. PharmWrite fosters collaboration between regulatory professionals, compliance teams, and other stakeholders by providing a centralized platform for communication and document sharing. This collaboration ensures that all parties are aligned, reducing miscommunication and streamlining the compliance process.
PharmWrite is designed to adapt to the evolving regulatory landscape and accommodate the needs of organizations of all sizes. The platform enables organizations to quickly adapt to regulatory changes, whether they are updates to laws, regulations, or market conditions. With PharmWrite, organizations can easily modify their compliance strategies, update submission materials, and implement new processes to remain compliant. Additionally, PharmWrite offers scalability, allowing organizations to handle a growing volume of regulatory submissions efficiently. As organizations expand their product portfolios, PharmWrite can support the increased compliance workload, ensuring continued regulatory success.
2024 © Enkrisi. All rights reserved.
744 South Street
Philadelphia, PA 19147
Call or Text
+1-866-ENKRISI (+1-866-365-7474)